source
- OncLive launches weekly quiz on recent FDA oncology approvalsOncLive released a weekly news quiz dated May 15, 2026, inviting readers to test their knowledge of recent oncology developments. The quiz focuses on three new FDA approvals in the oncology space…
- Durvalumab plus enfortumab vedotin improves survival outcomes in muscle-invasive bladder cancerA recent clinical study evaluated the perioperative use of durvalumab together with enfortumab vedotin in patients with muscle-invasive bladder cancer. The topline results indicated that the combi…